Nisa Investment Advisors
KZR

Nisa Investment Advisors’s Kezar Life Sciences KZR Stock Holding History

Nisa Investment Advisors’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5
Closed -$45 – 2957
2024
Q1 		$45 Hold
5
– – ﹤0.01% 2750
2023
Q4 		$47 Buy
+5
New +$44 ﹤0.01% 2631
2023
Q3 		– Sell
-375
Closed -$9.18K – 2807
2023
Q2 		$9.18K Buy
375
+338
+914% +$8.8K ﹤0.01% 2272
2023
Q1 		$1K Sell
37
-5
-12% -$289 ﹤0.01% 2412
2022
Q4 		$3K Buy
42
+5
+14% +$371 ﹤0.01% 2341
2022
Q3 		$3K Hold
37
– – ﹤0.01% 2339
2022
Q2 		$3K Hold
37
– – ﹤0.01% 2321
2022
Q1 		$6K Sell
37
-117
-76% -$16.8K ﹤0.01% 2288
2021
Q4 		$20K Hold
154
– – ﹤0.01% 1923
2021
Q3 		$13 Hold
154
– – ﹤0.01% 2174
2021
Q2 		$8 Hold
154
– – ﹤0.01% 2249
2021
Q1 		$9 Hold
154
– – ﹤0.01% 2218
2020
Q4 		$8K Buy
154
+80
+108% +$4.45K ﹤0.01% 2241
2020
Q3 		$4K Hold
74
– – ﹤0.01% 2209
2020
Q2 		$4K Sell
74
-280
-79% -$14.1K ﹤0.01% 2022
2020
Q1 		$15K Buy
+354
New +$14.4K ﹤0.01% 1769

Other funds holding KZR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Nisa Investment Advisors's KZR Position: Q2 2024 in Review

Nisa Investment Advisors sold out of Kezar Life Sciences (KZR) in Q2 2024, closing a stake of 5 shares — an estimated $45 sold.

Nisa Investment Advisors first reported a position in KZR in Q1 2020 and held it in 16 quarters. The position peaked at $20K in Q4 2021. 81 funds tracked by Wall St. Rank hold KZR as of Q2 2024.

  • Nisa Investment Advisors reported no remaining Kezar Life Sciences position as of Q2 2024 after selling out during the quarter.
  • Nisa Investment Advisors sold 5 Kezar Life Sciences shares in Q2 2024, an estimated $45.
  • Nisa Investment Advisors first reported a position in Kezar Life Sciences in Q1 2020 and held it in 16 quarters.
  • Nisa Investment Advisors's Kezar Life Sciences position peaked at $20K in Q4 2021.
  • 81 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2024.

Based on Nisa Investment Advisors's 13F filing for Q2 2024, filed 19 Jul 2024.